Back to search

Article

Current Evidence on the Involvement of RAGE-Diaph1 Signaling in the Pathology and Treatment of Neurodegenerative Diseases – an Overview

2025-07-25

Abstract excerpt

Neurodegenerative diseases are a group of disorders characterized by the progressive deterioration of structure and function of central nervous system neurons and include, among others, amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), Parkinson’s (PD), Alzheimer’s (AD) and Huntington’s (HD) diseases. And while all these diseases seem to have different genetic and environmental components, growing evid...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0a37ce13-4bf0-5fc2-a2e5-05d36ae5aba2
DOI
10.20944/preprints202507.2033.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Current Evidence on the Involvement of RAGE-Diaph1 Signaling in the Pathology and Treatment of Neurodegenerative Diseases – an OverviewDOI 10.20944/preprints202507.2033.v1
RAGE: The Beneficial and Deleterious Effects by Diverse Mechanisms of ActionsSemantic proximity
Absence of receptor for advanced glycation end product (RAGE) reduces inflammation and extends survival in the hSOD1 <sup>G93A</sup> mouse model of amyotrophic lateral sclerosisSemantic proximity
RAGE: A Multi-Ligand Receptor Unveiling Novel Insights in Health and DiseaseSemantic proximity
Pathological role of RAGE underlying progression of various diseases: its potential as biomarker and therapeutic targetSemantic proximity
Molecular Characteristics of RAGE and Advances in Small-Molecule InhibitorsSemantic proximity
High‐mobility group box 1 in Parkinson's disease: from pathogenesis to therapeutic approachesSemantic proximity
Identifying RAGE inhibitors as potential therapeutics for Alzheimer’s disease via integrated in-silico approachesSemantic proximity
The Translatability of Multiple Sclerosis Animal Models for Biomarkers Discovery and Their Clinical UseSemantic proximity
RAGE: therapeutic target and biomarker of the inflammatory response--the evidence mounts.Semantic proximity
Emerging role and mechanism of HACE1 in the pathogenesis of neurodegenerative diseases: A promising targetSemantic proximity
Neuregulins in Neurodegenerative DiseasesSemantic proximity
Soluble RAGE Treatment Delays Progression of Amyotrophic Lateral Sclerosis in SOD1 MiceSemantic proximity
Select a neighboring publication to make it the new centre.